|
gptkbp:instanceOf
|
gptkb:Controlled_substance_category
|
|
gptkbp:abusePotential
|
High
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:definedIn
|
gptkb:Controlled_Substances_Act
|
|
gptkbp:example
|
gptkb:Cocaine
gptkb:Amphetamine
gptkb:Dexmethylphenidate
gptkb:Hydrocodone
gptkb:Hydromorphone
gptkb:Meperidine
gptkb:Methylphenidate
gptkb:Morphine
gptkb:Oxycodone
gptkb:Pentobarbital
gptkb:Secobarbital
gptkb:Tapentadol
gptkb:Methadone
gptkb:Oxymorphone
Methamphetamine
Fentanyl
Codeine (high dose)
Glutethimide
Lisdexamfetamine
Nabilone
Phencyclidine (PCP)
Short-acting barbiturates
|
|
gptkbp:excludes
|
gptkb:Heroin
gptkb:Marijuana
gptkb:Benzodiazepines
|
|
gptkbp:legalStatus
|
Prescription only
|
|
gptkbp:medicalUse
|
gptkb:Accepted
|
|
gptkbp:penaltyForIllegalPossession
|
Severe
|
|
gptkbp:prescriptionRefillsAllowed
|
No
|
|
gptkbp:prescriptionType
|
Written or electronic only
|
|
gptkbp:regulates
|
gptkb:United_States_Drug_Enforcement_Administration
|
|
gptkbp:renewalPeriod
|
New prescription required for each fill
|
|
gptkbp:riskOfDependence
|
High
|
|
gptkbp:scheduleNumber
|
II
|
|
gptkbp:storage
|
Secure storage required
|
|
gptkbp:subject
|
DEA quotas
|
|
gptkbp:transferability
|
Not transferable between pharmacies
|
|
gptkbp:bfsParent
|
gptkb:21_U.S.C._§_812
gptkb:21_U.S.C._§_841
gptkb:21_U.S._Code_§_829
gptkb:21_U.S._Code_§_841
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Schedule II substances
|